Lorna Galleguillos*
Volume3-Issue10
Dates: Received: 2022-09-19 | Accepted: 2022-10-13 | Published: 2022-10-14
Pages: 1177-1179
Abstract
Monkeypox is a zoonotic viral disease that was identified in 1958 in research monkeys that came from Singapore. It is an orthopoxvirus that belongs to the Poxviridae family [1]. This viral infection was restricted to Africa but in the last year the cases started raising not only in Africa but in the rest of the world [1,2]. This is why it became a disease of interest; it is important to acknowledge its epidemiological behavior, risks and vaccines, especially in a world that was recently struck by COVID-19, challenging physicians in the way of treating and vaccinating their immunosuppressed patients.
FullText HTML
FullText PDF
DOI: 10.37871/jbres1573
Certificate of Publication
Copyright
© 2022 Galleguillos L. Distributed under Creative Commons CC-BY 4.0 
How to cite this article
Galleguillos L. Monkeypox and Immunosuppressed Neurological Patients: What can we Advise Vaccination in Multiple Sclerosis and Neuromyelitis Optica Patients? 2022 Oct 14; 3(10): 1177-1179. doi: 10.37871/jbres1573, Article ID: JBRES1573, Available at: https://www.jelsciences.com/articles/jbres1573.pdf
Subject area(s)
References
- Lum FM, Torres-Ruesta A, Tay MZ, Lin RTP, Lye DC, Rénia L, Ng LFP. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022 Oct;22(10):597-613. doi: 10.1038/s41577-022-00775-4. Epub 2022 Sep 5. PMID: 36064780; PMCID: PMC9443635.
- Jesmin S, Md. Arifur R, Sohael F, Shimojo N, Yamaguchi N, Kawano S, Moroi M. Monkeypox and an Interesting Look at Changes in Epidemiology. J Biomed Res Environ Sci. 2022 Aug 11;3(8):889-894. doi: 10.37871/jbres1528.
- Lai CC, Hsu CK, Yen MY, Lee PI, Ko WC, Hsueh PR. Monkeypox: An emerging global threat during the COVID-19 pandemic. J Microbiol Immunol Infect. 2022 Aug 5:S1684-1182(22)00102-5. doi: 10.1016/j.jmii.2022.07.004. Epub ahead of print. PMID: 35970757; PMCID: PMC9352646.
- Kwon SL, Ban S, Shin J, Bae H, Park H, Kwon GY. Monkeypox Vaccination in the Republic of Korea: Identifying the High-Risk Target Group. J Korean Med Sci. 2022 Jul 25;37(29):e239. doi: 10.3346/jkms.2022.37.e239. PMID: 35880509; PMCID: PMC9313979.
- Islam MR, Hossain MJ, Roy A, Hasan AHMN, Rahman MA, Shahriar M, Bhuiyan MA. Repositioning potentials of smallpox vaccines and antiviral agents in monkeypox outbreak: A rapid review on comparative benefits and risks. Health Sci Rep. 2022 Aug 23;5(5):e798. doi: 10.1002/hsr2.798. PMID: 36032515; PMCID: PMC9399446.
- See KC. Vaccination for Monkeypox Virus Infection in Humans: A Review of Key Considerations. Vaccines (Basel). 2022 Aug 18;10(8):1342. doi: 10.3390/vaccines10081342. PMID: 36016230; PMCID: PMC9413102.
- Farez MF, Correale J. Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis. Arch Neurol. 2011 Oct;68(10):1267-71. doi: 10.1001/archneurol.2011.131. Epub 2011 Jun 13. PMID: 21670384.
- Rao AK, Petersen BW, Whitehill F, Razeq JH, Isaacs SN, Merchlinsky MJ, Campos-Outcalt D, Morgan RL, Damon I, Sánchez PJ, Bell BP. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jun 3;71(22):734-742. doi: 10.15585/mmwr.mm7122e1. Erratum in: MMWR Morb Mortal Wkly Rep. 2022 Jul 08;71(27):886. PMID: 35653347; PMCID: PMC9169520.
- Winkelmann A, Loebermann M, Barnett M, Hartung HP, Zettl UK. Vaccination and immunotherapies in neuroimmunological diseases. Nat Rev Neurol. 2022 May;18(5):289-306. doi: 10.1038/s41582-022-00646-5. Epub 2022 Apr 6. PMID: 35388213; PMCID: PMC8985568.
